Researchers Identify New Drug Candidates to Treat DLST+ Tumors
The increased expression of DLST has recently been associated with increased tumor aggression and a... read more
January 19, 2023
Category: Oncotarget
Novel Antibody Drug Conjugate Improves Murine Acute Myeloid Leukemia
Researchers from Astellas Pharma Inc. investigated the efficacy of a novel antibody drug conjugate combined... read more
January 4, 2023
A New Method of Targeting Exosomes in Precision Medicine
Oncotarget published a new editorial perspective by Dr. Mujib Ullah, entitled, "The future of bioorthogonal-chemistry... read more
December 20, 2022
Plasma Growth Hormone in HCC: A Biomarker of Response to Atezo/Bev?
In a new study, researchers investigated the plasma growth hormone as a potential biomarker of... read more
December 8, 2022
Biomarkers May Predict Neoadjuvant Chemosensitivity in Bladder Cancer
In a new study, researchers aimed to identify and validate predictive biomarkers of response to... read more
November 15, 2022
New Target Fights Ferroptosis- and Radio-Resistance in Lung Cancers
Researchers published a research perspective about a recent study that uncovered FSP1 as a novel... read more
November 2, 2022
Synergy of HDACi, PARPi and Chemotherapeutics Against Blood Cancer
Researchers investigated the efficacy of HDAC inhibitors in combination with PARP inhibitors and chemotherapeutic drugs... read more
October 19, 2022
CRISPR Screens Identify Novel Targets for Personalized Cancer Therapy
In this trending new study, researchers used CRISPR-based genome-wide screens to identify genetic determinants of... read more
October 7, 2022
How High Altitudes Influence HIF-1, Gastric Cancer & Patient Survival
In a new study, researchers evaluated the high altitude in Ecuador and how it may... read more
September 27, 2022
Protein-Based Risk Model Predicts Esophageal Cancer Recurrence
Researchers developed a multi-protein expression-based risk model to predict recurrence-free survival for ESCC patients.The... read more
September 23, 2022